Table 1 Clinicopathologic features of 70 patients with non-small cell lung cancer
From: GAP43, a novel metastasis promoter in non-small cell lung cancer
Characteristics | Case, n (%) | Relapse-free cases, n (%) | Brain metastasis cases, n (%) | P value |
|---|---|---|---|---|
Age, years | 0.848 | |||
 < 65 | 48 (68.6) | 23 (47.9) | 25 (52.1) |  |
 ≥ 65 | 22 (31.4) | 10 (45.5) | 12 (54.5) |  |
 Median (5th–95th) | 60 (49.0–71.5) | 60 (46.6–73.1) | 60 (48.8–72.9) | 0.693a |
Sex | 0.729 | |||
 Male | 46 (65.7) | 21 (45.7) | 25 (54.3) |  |
 Female | 24 (34.3) | 12 (50.0) | 12 (50.0) |  |
Smoking | 0.713 | |||
 Never | 26 (37.1) | 13 (50.0) | 13 (50.0) |  |
 Ever/current | 44 (62.9) | 20 (45.5) | 24 (54.5) |  |
Histology | 0.678 | |||
 Adenocarcinoma | 40 (57.1) | 18 (45.0) | 22 (55.0) |  |
 Non-adenocarcinoma | 30 (42.9) | 15 (50.0) | 15 (50.0) |  |
Grade | 0.227 | |||
 Well | 28 (40.0) | 16 (57.1) | 12 (42.9) |  |
 Poor | 38 (54.3) | 16 (42.1) | 22 (57.9) |  |
 Missing | 4 (5.7) |  |  |  |
Clinical stage | 0.667 | |||
 I–II | 47 (67.1) | 23 (48.9) | 24 (51.1) |  |
 III | 23 (32.9) | 10 (43.5) | 13 (56.5) |  |